Placemark Investments’s West Pharmaceutical WST Stock Holding History

Placemark Investments’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.48M	Buy	27,787 +2,461	+10%	+$123K	0.03%	685
2014 Q3	$1.13M	Buy	25,326 +15,378	+155%	+$653K	0.02%	799
2014 Q2	$420K	Sell	9,948 -1,015	-9%	-$43.5K	0.01%	1239
2014 Q1	$483K	Sell	10,963 -931	-8%	-$43.8K	0.01%	1143
2013 Q4	$583K	Sell	11,894 -1,338	-10%	-$62.6K	0.01%	1062
2013 Q3	$545K	Buy	13,232 +48	+0.4%	+$1.83K	0.01%	1049
2013 Q2	$461K	Buy	+13,184	New	+$434K	0.01%	1067

Other funds holding WST

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Placemark Investments's WST Position: Q4 2014 in Review

Placemark Investments increased its West Pharmaceutical (WST) stake by 9.7% in Q4 2014, buying an estimated $123K and bringing the position to 27,787 shares worth $1.48M. The position accounts for 0.03% of the portfolio, ranked #685.

Placemark Investments first reported a position in WST in Q2 2013 and has held it in 7 quarters since. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

Placemark Investments held 27,787 shares of West Pharmaceutical worth $1.48M as of Q4 2014.
Placemark Investments bought 2,461 West Pharmaceutical shares in Q4 2014, an estimated $123K.
West Pharmaceutical made up 0.03% of Placemark Investments's portfolio in Q4 2014, its #685 holding.
Placemark Investments first reported a position in West Pharmaceutical in Q2 2013 and has held it in 7 quarters since.
225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.